Michel Torbey Lab

Research Interests

Dr. Michel Torbey’s laboratory engages in both preclinical and clinical studies pertaining to stroke, intracerebral hemorrhage (ICH), and traumatic brain injury (TBI). He is interested in understanding the mechanisms by which neuroinflammation elicits neuronal injury and contribute to secondary brain injury and cerebral edema. Preclinical models of ICH and TBI are used to study the role of mast cells in brain injury.

Current Research

 Our lab is studying the role of mast cells in rodent models of ICH and TBI in the preclinical setting. Clinical translational studies are also underway in acute stroke interventions, and outcome research.

The laboratory is also involved in cerebral cavernous malformation (CCM) research. As an Angioma Alliance Clinical Center of Excellence, We are participating in several NIH funded clinical trials.